Parkinson's Disease: Alpha-Synuclein

Alpha-synuclein is an integral component of Lewy bodies which are comprised of protein clumps and are a pathological hallmark of Parkinson’s disease. Here is the latest research.

June 25, 2020
Open Access

Parkinson's disease: etiopathogenesis and treatment

Journal of Neurology, Neurosurgery, and Psychiatry
Joseph Jankovic, Eng King Tan
July 1, 2020
Open Access

Appendectomy, Tonsillectomy and Parkinson's Disease Risk: A Swedish Register-Based Study

Frontiers in Neurology
Bojing LiuKarin Wirdefeldt
June 21, 2020

Application of yeast to studying amyloid and prion diseases

Advances in Genetics
Yury O ChernoffTatiana A Chernova
June 20, 2020

Comparative study between bone marrow mesenchymal stem cell and their conditioned medium in the treatment of rat model of Parkinsonism

Journal of Cellular Physiology
Soha AbdelwahabSara Mohamed Naguib Abdel-Hafez
July 2, 2020

Enhancing the Activity of Glucocerebrosidase as a Treatment for Parkinson Disease

CNS Drugs
Elisa Menozzi, Anthony H V Schapira
June 26, 2020
Open Access

Translation Imaging in Parkinson's Disease: Focus on Neuroinflammation

Frontiers in Aging Neuroscience
Sara BelloliMaria Carla Gilardi
July 1, 2020
Review

REM sleep behavior disorder (RBD)

Neurobiology of Disease
Michele T Hu
July 1, 2020
Comment / Editorial

Small-molecule inhibitors of α-synuclein for the treatment of Parkinson's disease: a patent landscape

Pharmaceutical Patent Analyst
Jacques Joubert
June 26, 2020
Review
Open Access

Chaperones and Proteostasis: Role in Parkinson's Disease

Diseases
Neha JoshiShirisha Nagotu
July 7, 2020
Review

Parkinson's disease a futile entangle of Mankind's credence on an herbal remedy: A review

Life Sciences
Yung Ming ChangChih Yang Huang
June 21, 2020
Review
Open Access

The Future of Targeted Gene-Based Treatment Strategies and Biomarkers in Parkinson's Disease

Biomolecules
Alexia PolissidisHardy J Rideout
July 7, 2020

Copper and iron ions accelerate the prion-like propagation of α-synuclein: A vicious cycle in Parkinson's disease

International Journal of Biological Macromolecules
Yang LiKun Huang

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/parkinsons-disease-alpha-synuclein/caab44a1-bacf-4bc9-8951-beb5f3e04c78